 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Endocare Cryoablation
The evolution of cryoablation techniques, from the emergence decades ago to the recent success of new technologies has increased and enhanced the options available to physicians worldwide. Endocare’s unique approach of precise technology and accurate control have improved intervention in the treatment of benign and malignant tumors throughout the body. Endocare’s cryoablation experience in open, laparoscopic and percutaneous applications spans 10 years in prostate and 9 years in renal.10 The continued advances, in both method and technology of cryoablation applications point to a significant difference in the future of oncology treatment and the prospects for its patients.
10Davol PE, et al: Long-term Results of Cryoablation for Renal Cancer and Complex Renal Masses. J Urol 68: 2-6, 2006.
© 2003-2004 Endocare, Inc. All rights reserved.
Endocare, Inc. supports